Oncologia

Benefícios de 15 anos do rastreamento por sigmoidoscopia na incidência e na mortalidade de câncer colorretal: análise agrupada de estudos randomizados.

17 Out, 2022 | 13:34h

15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality: A Pooled Analysis of Randomized Trials – Annals of Internal Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women – American College of Physicians

Conteúdos relacionados:

RCT | Effect of colonoscopy screening on risks of colorectal cancer and related death.

RCT: One-time flexible sigmoidoscopy screening is associated with long-term reduction in colorectal cancer incidence and mortality.

ACP Guideline: Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults

BMJ Guideline: Colorectal Cancer Screening with Fecal Immunochemical Testing, Sigmoidoscopy or Colonoscopy

Current and future colorectal cancer screening strategies – Nature Reviews Gastroenterology & Hepatology (se o acesso a este link for pago, tente este em PMC)

Consensus Statement: U.S. Multi-Society Task Force on Colorectal Cancer now suggests average-risk CRC screening begins at age 45.

USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.

ACG Clinical Guidelines: Start colorectal cancer screening at 45

 

Comentário no Twitter

A pooled analysis evaluating 15-yr effect of sigmoidoscopies found that receiving 1 #sigmoidoscopy significantly reduces long-term incidence of CRC in men and women: https://t.co/QXj5VRMHeo pic.twitter.com/s82sOJmBzr

— Annals of Int Med (@AnnalsofIM) October 11, 2022

 

---

Diretriz | Manejo periprocedimento de agentes antitrombóticos e trombocitopenia para procedimentos comuns em oncologia.

17 Out, 2022 | 13:31h

Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH – Journal of Thrombosis & Haemostasis

 

---

Estudo de coorte | Prognóstico oncológico de longo prazo com cirurgia mamária de acesso mínimo vs. cirurgia mamária convencional.

17 Out, 2022 | 13:22h

Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery – JAMA Surgery

 

Comentário no Twitter

A single-center retrospective cohort study found that the long-term outcomes of minimal-access breast surgery are not significantly different from those of conventional #BreastSurgery in patients with stage 0-III #BreastCancer. https://t.co/SMQWCNSa4X

— JAMA Surgery (@JAMASurgery) October 6, 2022

 

---

Revisão | Cardiotoxicidade permissiva: a base clínica da cardio-oncologia.

17 Out, 2022 | 13:17h

Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology – JACC: CardioOncology

 

---

Estudo randomizado | Efeito do rastreamento com colonoscopia sobre os riscos de câncer colorretal e morte relacionada.

17 Out, 2022 | 12:59h

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentários:

In gold-standard trial, invitation to colonoscopy reduced cancer incidence but not death – STAT

New study examines the effectiveness of colonoscopies – CNN

 

---

Recomendações de consenso para rastreamento e manejo de sobreviventes de câncer infantil quanto ao risco para cardiomiopatia.

17 Out, 2022 | 12:50h

Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy – JACC: CardioOncology

Conteúdos relacionados:

Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors – Journal of Clinical Oncology

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC) – European Heart Journal – Cardiovascular Imaging

Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations – Annals of Oncology

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement from the American Heart Association – Circulation

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations – Revista Espanola de Cardiologia

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology—Part 1: acute coronary syndromes and acute pericardial diseases – European Heart Journal. Acute Cardiovascular Care

Brazilian Cardio-oncology Guideline – 2020 – Arquivos Brasileiros de Cardiologia

AHA Statement: Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors

 

---

Estudo randomizado | Toripalimabe com quimioterapia para pacientes com câncer de pulmão de não pequenas células avançado e sem tratamento.

17 Out, 2022 | 12:46h

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01) – Journal of Clinical Oncology

Comentário: CHOICE-01: Toripalimab Plus Chemotherapy Improves Survival in Advanced NSCLC Without Actionable Mutations – The ASCO Post

 

---

Coorte retrospectiva | Desfechos no neuroblastoma recidivante tratado com irinotecano/temozolomida/dinutuximabe/GM-CSF.

17 Out, 2022 | 12:45h

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor – Journal of Clinical Oncology

 

---

Consenso | Corticosteroides na oncologia: uso, uso excessivo, indicações, contraindicações.

6 Out, 2022 | 12:54h

Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper – Critical Reviews in Oncology/Hematology

Conteúdo relacionado: RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events.

 

---

Podcast | Pólipos, polipectomia e vigilância.

6 Out, 2022 | 12:36h

Polyps, polypectomy & surveillance with Dr. Jennifer Maranki – The Curbsiders

 

---